Magazine article Drug Topics

Lotrimin Ultra Is Latest Product to Go from Rx to OTC

Magazine article Drug Topics

Lotrimin Ultra Is Latest Product to Go from Rx to OTC

Article excerpt

Schering-Plough's HealthCare Products, Berkeley Heights, N.J., is getting set to roll out Lotrimin Ultra (butenafine HCl 1% cream). Last month, the Food & Drug Administration OK'd the OTC switch of the prescription cream for the treatment of interdigital tinea pedis (athlete's foot), tinea corporis (ringworm), and tinea cruris (jock itch).

Lotrimin Ultra, to be launched during the first quarter of this year, is the third-generation of OTC athlete's foot antifungals in the Lotrimin AF family. Other OTC products from the company include clotrimazole 1%, available as a cream, solution, and lotion, and miconazole nitrate 2%, available in powder, deodorant powder, spray powder, and spray liquid forms.

Lotrimin Ultra, which was approved in the same form and dosage strength as Schering's Rx medication Mentax, has a suggested retail price of $7.99-$9.99 for a 12-gm tube and $11.99-$14.99 for a 24-gm tube. According to Jim Lawenda, associate director for consumer promotions and media, Mentax will still be available for "certain applications as an Rx."

The recommended dosage of Mentax for athlete's foot is a twice-daily application for one week or oncedaily for four weeks. For ringworm and jock itch, the dosage is once a day for two weeks. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.